Eurofins Advinus offers comparative, non-clinical pharmacokinetic (PK) and tissue distribution (TD) studies for Amphotericin B liposomal injections. Leveraging our expertise in LC-MS/MS assays, we can effectively determine Amphotericin B levels in plasma and tissue samples. We have completed such tests for seven test products. These studies were designed to meet the stringent requirements set forth by the European Medicines Agency (EMA). By providing crucial data on drug movement and distribution in the body, our Amphotericin B PK/TD studies play a vital role in optimizing drug delivery for these novel antifungal therapies. This can lead to the development of safer and more targeted treatments for invasive fungal infections. Contact us now!
